Efficacy and Mechanism of the Combination of PARP and CDK4/6 Inhibitors in the Treatment of Triple-negative Breast Cancer
Xiu-Zhi Zhu(Shanghai Medical College of Fudan University), Zhonghua Wang(Shanghai Medical College of Fudan University)
Cited by 0
Related Papers
Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer
|Journal of Experimental & Clinical Cancer Research|2021|89